Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01518777 · ClinicalTrials.gov registry record · NA
Reducing Radioisotope Dose: the Half-Dose CZT Study
A NA study of Coronary Artery Disease, sponsored by S.M.Chang, MD.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT01518777 is a NA study of Coronary Artery Disease that has completed, run by S.M.Chang, MD. The registered enrollment target is 74 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01518777, a NA study of Coronary Artery Disease, has completed, sponsored by S.M.Chang, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to see whether cardiac imaging can be performed using half the standard dose of radioisotope.
Conditions Studied
Interventions
- OTHER Half-dose isotope for NuclearStressTest
Study Locations (1)
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01518777
The ClinicalTrials.gov registry entry for NCT01518777 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower). The listed sponsor is S.M.Chang, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Half-dose isotope for NuclearStressTest is the first listed.
NCT01518777 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01518777 about?
NCT01518777 is a clinical study titled "Reducing Radioisotope Dose: the Half-Dose CZT Study". This is a pilot study to see whether cardiac imaging can be performed using half the standard dose of radioisotope.
What is the current status of trial NCT01518777?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2012-01. Estimated completion is 2016-12-16.
What conditions does trial NCT01518777 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT01518777?
The interventions under investigation include: Half-dose isotope for NuclearStressTest (OTHER).
Who is sponsoring clinical trial NCT01518777?
This trial is sponsored by S.M.Chang, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01518777 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.